[av_textblock size=” font_color=” color=” av-desktop-hide=” av-medium-hide=” av-small-hide=” av-mini-hide=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=”]
[/av_textblock]
[av_one_full first min_height=” vertical_alignment=” space=” custom_margin=” margin=’0px’ padding=’0px’ border=” border_color=” radius=’0px’ background_color=” src=” background_position=’top left’ background_repeat=’no-repeat’ animation=”]
[av_heading heading=’WV pediatricians alerted on dengue vaccine ‘ tag=’h3′ style=’blockquote modern-quote’ size=’30’ subheading_active=’subheading_below’ subheading_size=’15’ padding=’10’ color=” custom_font=” av-medium-font-size-title=” av-small-font-size-title=” av-mini-font-size-title=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” admin_preview_bg=”]
BY GLENDA SOLOGASTOA
[/av_heading]
[av_textblock size=’18’ font_color=” color=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” admin_preview_bg=”]
ILOILO City – Were there children in Western Visayas vaccinated with anti-dengue vaccine Dengvaxia?
The Philippine Pediatric Society (PDS) wanted to know and had asked member pediatricians in the region to furnish it with the names of patients – if any – that got inoculated.
Department of Health (DOH) in Western Visayas is closely coordinating with PDS, said Dr. Renilyn Reyes, head of the regional health office’s Family, Health and Nutrition Cluster and a pediatrician herself.
Pediatricians are doctors specializing in the health of children, including their physical, behavior and mental health issues. They are trained to diagnose and treat childhood illnesses, from minor health problems to serious diseases.
Reyes said pediatricians will also have a meeting with Dengvaxia manufacturer Sanofi Pasteur next week to clarify issues related to the vaccine.
In Nov. 29, Sanofi announced that post-clinical trial study indicated an increased risk of hospitalization for dengue and “severe” dengue for those vaccinated but not previously infected by the dengue virus.
Reyes said DOH-6 is not discounting the possibility that children from other regions vaccinated with Dengvaxia may have moved here, thus it has started surveillance on hospitals and health centers in the region.
DOH’s anti-dengue vaccination program only covered four regions – National Capital Region, Regions 3 and 4A, and 7.
Reyes said DOH-6 instructed all public health providers to get the details of suspected dengue patients.
“I-ask kon nabakunahan,” said Reyes.
Those with symptoms of dengue should seek medical attention immediately, she stressed.
Dengue hemorrhagic fever is an acute viral infection that affects infants, young children and adults. It is transmitted by day-biting mosquitoes that live and breed in clear, stagnant water.
Symptoms include headache; muscle, bone and joint pain; nausea; vomiting; pain behind the eyes; swollen glands; and rash./PN
[/av_textblock]
[/av_one_full]
